Fasciola hepatica infection: clinical and computerized tomographic findings of ten patients.
OBJECTIVE
Fasciola hepatica is the cause of liver infection, fascioliasis. Although rare, it is still a problem even in developed countries. In this study, the clinical and computerized tomographic findings of 10 patients diagnosed with fascioliasis are summarized.


METHODS
The medical records of the patients with fascioliasis were retrospectively examined. Clinical, laboratory findings and computerized tomographic results were recorded.


RESULTS
Abdominal pain, fever, eosinophilia and abnormal liver function tests were the most commonly encountered symptoms and signs. One patient was human immunodeficiency virus -positive with active tuberculosis. Serologic test for fasciola hepatica was positive in all patients. Nodular masses without prominent enhancement, and branching low-attenuated tubular lesions were the most commonly seen tomographic findings and were supportive for the diagnosis. All except the HIV-positive patient received bithionol therapy; six patients responded well, two lost contact with the clinic and one patient who was unresponsive to bithionol therapy received triclabendazole. During follow-up of the six patients who responded, all the clinical and radiological findings regressed.


CONCLUSIONS
In any patient with peripheral eosinophilia, abdominal pain and elevated liver enzymes, especially when CT reveals tubular and nodular hypodense lesions particularly in subcapsular area, F. hepatica infection should be considered. Either triclabendazole or bithionol can be used effectively for the treatment.
Aksoy
Duygu Yazgan
DY
Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey. duyguyaks@yahoo.com
Kerimoğlu
Ulkü
U
Oto
Aytekin
A
Ergüven
Sibel
S
Arslan
Serap
S
Unal
Serhat
S
Batman
Figen
F
Bayraktar
Yusuf
Y
D015746:Abdominal Pain / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000980:Antiplatyhelmintic Agents / Q000627:therapeutic use; D001735:Bithionol / Q000627:therapeutic use; D005211:Fascioliasis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed
D000980:Antiplatyhelmintic Agents; D001735:Bithionol